MaxCyte, Inc. (MXCT)
USD 2.32
(-5.51%)
USD 2.32
(-5.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -37.92 Million USD | -91.71% |
| 2022 | -19.78 Million USD | 1.72% |
| 2021 | -20.12 Million USD | -59.2% |
| 2020 | -12.64 Million USD | 6.88% |
| 2019 | -13.57 Million USD | -53.07% |
| 2018 | -8.86 Million USD | 10.57% |
| 2017 | -9.91 Million USD | -196.43% |
| 2016 | -3.34 Million USD | -131.44% |
| 2015 | -1.44 Million USD | 21.31% |
| 2014 | -1.83 Million USD | -91.71% |
| 2013 | -958.2 Thousand USD | 51.81% |
| 2012 | -1.98 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.37 Million USD | 1.59% |
| 2024 Q1 | -9.52 Million USD | -80.52% |
| 2023 Q2 | -10.51 Million USD | -22.43% |
| 2023 Q3 | -11.25 Million USD | -7.04% |
| 2023 Q1 | -8.58 Million USD | -199.31% |
| 2023 Q4 | -5.27 Million USD | 53.1% |
| 2023 FY | -37.92 Million USD | -91.71% |
| 2022 Q4 | -2.86 Million USD | 55.41% |
| 2022 Q3 | -6.43 Million USD | 17.32% |
| 2022 Q2 | -7.78 Million USD | -95.74% |
| 2022 FY | -19.78 Million USD | 1.72% |
| 2022 Q1 | -3.97 Million USD | 18.44% |
| 2021 Q4 | -4.87 Million USD | -81.85% |
| 2021 FY | -20.12 Million USD | -59.2% |
| 2021 Q2 | -4.42 Million USD | 37.77% |
| 2021 Q3 | -2.68 Million USD | 39.38% |
| 2021 Q1 | -7.1 Million USD | -167.96% |
| 2020 FY | -12.64 Million USD | 6.88% |
| 2020 Q3 | -3.09 Million USD | -3.15% |
| 2020 Q4 | -2.65 Million USD | 14.43% |
| 2020 Q2 | -3 Million USD | 1.89% |
| 2020 Q1 | -3.06 Million USD | -79.02% |
| 2019 Q4 | -1.71 Million USD | 0.0% |
| 2019 FY | -13.57 Million USD | -53.07% |
| 2019 Q3 | -1.71 Million USD | 63.89% |
| 2019 Q2 | -4.73 Million USD | 0.0% |
| 2019 Q1 | -4.73 Million USD | -132.05% |
| 2018 Q4 | -2.04 Million USD | 0.0% |
| 2018 FY | -8.86 Million USD | 10.57% |
| 2018 Q2 | -2.39 Million USD | 0.0% |
| 2018 Q3 | -2.04 Million USD | 14.7% |
| 2018 Q1 | -2.39 Million USD | 14.78% |
| 2017 Q1 | -2.15 Million USD | -106.88% |
| 2017 Q2 | -2.15 Million USD | 0.0% |
| 2017 Q4 | -2.8 Million USD | 0.0% |
| 2017 Q3 | -2.8 Million USD | -30.6% |
| 2017 FY | -9.91 Million USD | -196.43% |
| 2016 Q1 | -886.05 Thousand USD | -15.92% |
| 2016 FY | -3.34 Million USD | -131.44% |
| 2016 Q4 | -1.03 Million USD | 0.0% |
| 2016 Q3 | -1.03 Million USD | -17.31% |
| 2016 Q2 | -886.05 Thousand USD | 0.0% |
| 2015 Q3 | -764.35 Thousand USD | 23.16% |
| 2015 Q2 | -994.7 Thousand USD | 0.0% |
| 2015 Q1 | -994.7 Thousand USD | -19.6% |
| 2015 FY | -1.44 Million USD | 21.31% |
| 2015 Q4 | -764.35 Thousand USD | 0.0% |
| 2014 FY | -1.83 Million USD | -91.71% |
| 2014 Q4 | -831.7 Thousand USD | 0.0% |
| 2014 Q1 | -1.04 Million USD | 0.0% |
| 2014 Q2 | -1.04 Million USD | 0.0% |
| 2014 Q3 | -831.7 Thousand USD | 20.41% |
| 2013 FY | -958.2 Thousand USD | 51.81% |
| 2012 FY | -1.98 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 38.455% |
| IceCure Medical Ltd | -14.65 Million USD | -158.825% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -219.769% |
| Acutus Medical, Inc. | -81.66 Million USD | 53.562% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 6023.655% |
| Bioventus Inc. | -156.23 Million USD | 75.726% |
| BrainsWay Ltd. | -4.19 Million USD | -803.574% |
| Cerus Corporation | -37.48 Million USD | -1.158% |
| Venus Concept Inc. | -37.25 Million USD | -1.807% |
| Envoy Medical, Inc. | -29.9 Million USD | -26.799% |
| CVRx, Inc. | -41.19 Million USD | 7.952% |
| electroCore, Inc. | -18.83 Million USD | -101.354% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -328.508% |
| Inogen, Inc. | -102.44 Million USD | 62.984% |
| OrthoPediatrics Corp. | -20.97 Million USD | -80.81% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 27.993% |
| Spectral AI, Inc. | -20.85 Million USD | -81.85% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -175.9% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 37.602% |
| Nexalin Technology, Inc. | -4.64 Million USD | -715.775% |
| Orthofix Medical Inc. | -151.39 Million USD | 74.951% |
| PAVmed Inc | -64.17 Million USD | 40.907% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 27.72% |
| RxSight, Inc. | -48.6 Million USD | 21.982% |
| Sight Sciences, Inc. | -55.54 Million USD | 31.728% |
| SI-BONE, Inc. | -43.33 Million USD | 12.491% |
| TELA Bio, Inc. | -46.66 Million USD | 18.732% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 23.43% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -179.195% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 35.765% |
| LivaNova PLC | 17.54 Million USD | 316.135% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -246.161% |
| Talis Biomedical Corporation | -62 Million USD | 38.841% |
| 908 Devices Inc. | -36.39 Million USD | -4.187% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 79.681% |
| Nemaura Medical Inc. | -14.14 Million USD | -168.126% |
| NeuroPace, Inc. | -32.95 Million USD | -15.072% |
| LENSAR, Inc. | -14.38 Million USD | -163.665% |
| Apyx Medical Corporation | -18.71 Million USD | -102.656% |
| Cutera, Inc. | -162.83 Million USD | 76.71% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -250.166% |
| BioSig Technologies, Inc. | -29.04 Million USD | -30.584% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 54.126% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -71.683% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 155.982% |
| Axonics, Inc. | -6.08 Million USD | -522.914% |
| Outset Medical, Inc. | -172.79 Million USD | 78.053% |
| IRIDEX Corporation | -9.57 Million USD | -296.27% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 64.189% |
| IRadimed Corporation | 17.19 Million USD | 320.575% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -360.007% |
| INVO Bioscience, Inc. | -8.03 Million USD | -371.995% |
| Telesis Bio, Inc. | -47.72 Million USD | 20.537% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 470.233% |
| Varex Imaging Corporation | -47.7 Million USD | 20.497% |
| Quipt Home Medical Corp. | -2.78 Million USD | -1262.177% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -236.018% |
| Pulmonx Corporation | -60.84 Million USD | 37.671% |
| Dynatronics Corporation | -2.69 Million USD | -1305.743% |
| Modular Medical, Inc. | -17.47 Million USD | -117.075% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -233.038% |
| Semler Scientific, Inc. | 20.58 Million USD | 284.244% |
| InMode Ltd. | 197.91 Million USD | 119.161% |
| Bruker Corporation | 427.2 Million USD | 108.877% |
| Cytosorbents Corporation | -28.5 Million USD | -33.029% |
| DexCom, Inc. | 541.5 Million USD | 107.003% |
| Align Technology, Inc. | 445.05 Million USD | 108.521% |
| Viveve Medical, Inc. | -22.02 Million USD | -72.166% |
| ZimVie Inc. | -393.28 Million USD | 90.357% |
| Movano Inc. | -29.28 Million USD | -29.505% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -212.175% |
| Nexalin Technology, Inc. | -4.64 Million USD | -715.775% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 6023.655% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 82.964% |
| Profound Medical Corp. | -28.56 Million USD | -32.742% |
| Insulet Corporation | 206.3 Million USD | 118.382% |
| enVVeno Medical Corporation | -23.51 Million USD | -61.265% |
| Surmodics, Inc. | -11.54 Million USD | -228.565% |
| iCAD, Inc. | -4.84 Million USD | -682.401% |
| Nuwellis, Inc. | -20.2 Million USD | -87.654% |
| Biotricity, Inc. | -14.09 Million USD | -169.067% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 69.27% |
| Aethlon Medical, Inc. | -12.2 Million USD | -210.636% |
| InspireMD, Inc. | -19.91 Million USD | -90.415% |
| PAVmed Inc. | -64.17 Million USD | 40.907% |
| BIOLASE, Inc. | -20.63 Million USD | -83.807% |
| Beyond Air, Inc. | -60.24 Million USD | 37.049% |
| FONAR Corporation | 10.56 Million USD | 458.868% |
| AxoGen, Inc. | -21.71 Million USD | -74.632% |
| Vivani Medical, Inc. | -25.65 Million USD | -47.836% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 232.993% |
| Inari Medical, Inc. | -1.63 Million USD | -2218.032% |
| UFP Technologies, Inc. | 44.92 Million USD | 184.416% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -638.904% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -474.138% |
| Tenon Medical, Inc. | -15.58 Million USD | -143.393% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -145.838% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -7.331% |
| AdaptHealth Corp. | -678.89 Million USD | 94.414% |
| Sintx Technologies, Inc. | -8.25 Million USD | -359.172% |
| NanoVibronix, Inc. | -3.71 Million USD | -921.908% |
| Quanterix Corporation | -32.33 Million USD | -17.285% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -236.018% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 7919.175% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 87.637% |
| TransMedics Group, Inc. | -25.02 Million USD | -51.522% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -71.341% |
| NeuroMetrix, Inc. | -6.52 Million USD | -480.796% |
| Hyperfine, Inc. | -44.23 Million USD | 14.275% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 51.692% |
| Biomerica, Inc. | -5.97 Million USD | -534.376% |
| Bone Biologics Corporation | -8.94 Million USD | -323.781% |
| AVITA Medical, Inc. | -39.16 Million USD | 3.179% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -280.987% |
| Silk Road Medical, Inc | -55.74 Million USD | 31.968% |